Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

CLINSPECT-M: Clinical mass spectrometry center for molecular brain research in Munich

11.02.2020

In a joint large-scale project, Munich scientists from proteomics, computer science and medicine investigate the causes of disorders of the central nervous system, how they can be diagnosed and how treatment response can be monitored. To this end, the Federal Ministry of Education and Research (BMBF) provides funding of 6 million euros to set up a clinical mass spectrometry center in Munich (CLINSPECT-M) for an initial period of three years.

Mass spectrometry permits the simultaneous and quantitative determination of minute quantities of thousands of biomolecules from tissues or body fluids. Such molecular profiles for proteins will now be brought into clinical use for the first time.


Entrance to the mass spectrometer

Wolfgang Filser / TUM


Quadrupole: Part of the ion optics of a mass spectrometer.

Wolfgang Filser / TUM

New insights into the diagnosis and monitoring of disease

Munich is one of Germany's leading centers of neuroscience. The scientists involved in the new consortium intend to demonstrate that mass spectrometric protein analysis is suitable for the detection of clinically usable biomarkers.

... more about:
»BMBF »Biomarkers »LMU »STROKE »Spectrometry »TUM »diagnosis »proteins

The partners involved are TUM and its University Hospital ‘rechts der Isar’, the Ludwig-Maximilians-Universität München (LMU) with its University Hospital, the Helmholtz Zentrum München and the Max Planck Institute of Biochemistry. The partners will initially be funded with approximately 6 million euros over the next three years.

"As a core element of ‘TUM Agenda 2030’ – our strategic vision for the future –, this powerful cooperation in the clinical neurosciences constitutes a significant advance in systematically uniting Munich researchers as part of our ONE MUNICH strategy," says Prof. Thomas F. Hofmann, President of TUM.

The members of the consortium ‘Clinical Mass Spectrometry Center Munich (CLINSPECT-M)’ see an extremely high demand for biomarkers for diagnosis, therapy decisions and monitoring of therapy response.

Everything revolves around the brain

The Clinspect-M network covers four major areas of application in medicine:

◾Multiple sclerosis: protein profiles of the cerebrospinal fluid of 4,000 patients should help physicians to find disease-specific fingerprints that can be used in clinical diagnosis.

◾Alzheimer's disease: clinical studies involving hundreds of patients will be used to find biomarkers that indicate whether a drug is effective or not.

◾Stroke: the examination of thousands of patient samples will identify proteins that indicate brain damage caused by a stroke and distinguish stroke from other causes.

◾Brain tumors: hundreds of cancer patients are examined with the aim of finding molecular targets for personalized therapy decisions.

"By using bioinformatics to bring together medical information and data from mass spectrometry, we will gain a better understanding of the complex interrelationships between these diseases and translate this understanding into medical practice," explains co-spokesperson Prof. Daniel Teupser, Director of the Institute of Laboratory Medicine at LMU.

More information:

With its initiative "Research Nodes for Mass Spectrometry in Systems Medicine", the BMBF (Federal Ministry of Education and Research) supports the implementation of the latest technologies in medical practice. In a highly competitive procedure, four consortia from Munich, Berlin, Heidelberg and Mainz were selected from around 30 applicants.

In addition to BMBF funding, the project also receives financial support from the Free State of Bavaria, TUM and LMU.

Wissenschaftliche Ansprechpartner:

Prof. Dr. Bernhard Küster
Technical University of Munich
Chair of Proteomics and Bioanalytics
phone: +49-8161-7-5696
kuster(at)tum.de

Weitere Informationen:

https://mediatum.ub.tum.de/1537625 (high resolution images)
https://www.synergy-munich.de/index.html (The Excellence Cluster Synergy is also a cooperative venture between TUM and LMU.)

Dr. Ulrich Marsch | Technische Universität München

Further reports about: BMBF Biomarkers LMU STROKE Spectrometry TUM diagnosis proteins

More articles from Physics and Astronomy:

nachricht K-State study reveals asymmetry in spin directions of galaxies
03.06.2020 | Kansas State University

nachricht The cascade to criticality
03.06.2020 | ETH Zurich Department of Physics

All articles from Physics and Astronomy >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: K-State study reveals asymmetry in spin directions of galaxies

Research also suggests the early universe could have been spinning

An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...

Im Focus: New measurement exacerbates old problem

Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.

Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

An MRI technique has been developed to improve the detection of tumors

03.06.2020 | Medical Engineering

K-State study reveals asymmetry in spin directions of galaxies

03.06.2020 | Physics and Astronomy

The cascade to criticality

03.06.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>